Healthcare

According to a market report by Lucintel, the future of the high potency API market looks promising with opportunities in oncology, glaucoma, hormonal imbalance, and other therapeutic applications. The global high potency API market is expected to reach an estimated $38.1 billion by 2028 with a CAGR of 8.7% from 2023 to 2028. The major drivers for this market are growing demand for oncology drugs and antibody-drug conjugates, increasing demand for outsourcing HPAPIs, and growing focus on precision medicine.



In this market, synthetic API market and biotech API market are the two major types of synthesis segments. Lucintel forecasts that synthetic API is expected to remain the larger type of synthesis segment over the forecast period due to growing number of new APIs and increasing adoption of these APIs in treating a wide range of diseases.



Within this market, the oncology segment is expected to witness the highest growth over the forecast period due to increasing cases of cancer across the globe.



North America is expected to remain the largest region over the forecast period due to growing incidence of chronic diseases and increased awareness of the high potency APIs in the treatment of serious ailments.

Pfizer, F. Hoffmann-La Roche, Sanofi, Bristol-Myers Squibb, Bayer AG, Novartis International AG, Boehringer Ingelheim International GmbH, Teva Pharmaceutical Industries, Eli Lilly and Company, Merck & Co, AbbVie, and Viatris are the major suppliers in the global high potency API market.



Lucintel, a leading global strategic consulting and market research firm, has analyzed growth opportunities in the global high potency API market by type, type of synthesis, type of manufacturers, therapeutic application, and region. Lucintel has compiled a comprehensive research report titled “Growth Opportunities in the Global High Potency API Market 2023-2028: Trends, Forecast, and Opportunity Analysis.” The Lucintel report serves as a catalyst for growth strategy, as it provides comprehensive data and analysis on trends, key drivers, and directions. The study includes trends and forecast for the global high potency API market by type, type of synthesis, type of manufacturers, therapeutic application, and region, as follows:

This more than 150-page research report will enable you to make confident business decisions in this globally competitive marketplace. For a detailed table of contents, contact Lucintel at +1-972-636-5056 or email us at helpdesk@lucintel.com.

 

Lucintel, the premier global Management Consulting and market research firm, creates winning strategies for growth. Lucintel offers market assessments, competitive analysis, opportunity analysis, Growth Consulting, M&A, and Due diligence services to executives and key decision-makers in a variety of industries. For further information, visit www.lucintel.com.

 

Q.1. What are some of the most promising, high-growth opportunities for the global high potency API market by type (innovative API market and generic API market), type of synthesis (synthetic API market and biotech API market), type of manufacturers (captive API market and merchant API market), therapeutic application (oncology, hormonal imbalance, glaucoma, and other therapeutic applications) and others), and region (North America, Europe, Asia Pacific, and the Rest of the World)?

Q.2. Which segments will grow at a faster pace and why?

Q.3. Which region will grow at a faster pace and why?

Q.4. What are the key factors affecting market dynamics? What are the key challenges and business risks in this market?

Q.5. What are the business risks and competitive threats in this market?

Q.6. What are the emerging trends in this market and the reasons behind them?

Q.7. What are some of the changing demands of customers in the market?

Q.8. What are the new developments in the market? Which companies are leading these developments?

Q.9. Who are the major players in this market? What strategic initiatives are key players pursuing for business growth?

Q.10. What are some of the competing products in this market and how big of a threat do they pose for loss of market share by material or type substitution?

Q.11. What M&A activity did occur in the last five years and how did they impact the industry?